Overview

Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine

Status:
Completed
Trial end date:
2020-09-24
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate drug interaction between HS-10234 and Emtricitabine after multiple dose in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Treatments:
Emtricitabine